Far Northern Resources Limited (FNR.AX)
AUD 0.11
(-21.43%)
AUD 0.11
(-21.43%)
| Breakdown | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Operating Cash Flow | -1.01 Million | -308.2 Thousand | -82.17 Thousand | -231.9 Thousand |
| Net Income | -1.07 Million | -394.99 Thousand | -91.71 Thousand | -286.77 Thousand |
| Depreciation & Amortization | 106.69 Thousand | 65.6 Thousand | 66.4 Thousand | 3199.00 |
| Deferred income taxes | - | - | - | - |
| Stock-based compensation | - | - | - | - |
| Change in working capital | -28.4 Thousand | 54.28 Thousand | -140.45 Thousand | 73.24 Thousand |
| Other non-cash items | -14.36 Thousand | 49.61 Thousand | 346.71 Thousand | -136.35 Thousand |
| Investing Cash Flow | -13.06 Thousand | -1128.00 | - | -991.67 Thousand |
| Investments in PPE | 1.01 Million | 308.2 Thousand | - | - |
| Acquisitions | - | - | - | - |
| Investment purchases | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - |
| Other Investing Activities | -13.06 Thousand | -1128.00 | - | -991.67 Thousand |
| Financing Cash Flow | 4.16 Million | 725 Thousand | - | 1.13 Million |
| Debt repayment | - | - | - | - |
| Dividends payments | - | - | - | - |
| Common Stock Repurchased | - | - | - | - |
| Common Stock Issuance | 4.16 Million | 725 Thousand | - | - |
| Other Financing Activities | - | - | - | 1.13 Million |
| Accounts receivables | -39.51 Thousand | -6915.00 | -1928.00 | 7984.00 |
| Accounts payables | 11.1 Thousand | 55.41 Thousand | -128.39 Thousand | 113.2 Thousand |
| Inventory | - | - | - | - |
| Other working capital | - | 5787.00 | -10.13 Thousand | -47.94 Thousand |
| Cash at beginning of period | 425.89 Thousand | 10.22 Thousand | 92.4 Thousand | 183.79 Thousand |
| Cash at end of period | 3.56 Million | 425.89 Thousand | 10.22 Thousand | 92.4 Thousand |
| Capital Expenditure | 1.01 Million | 308.2 Thousand | - | - |
| Effect of forex changes on cash | - | - | - | - |
| Net cash flow / Change in cash | 3.13 Million | 415.66 Thousand | -82.17 Thousand | -91.39 Thousand |
| Free Cash Flow | - | - | -82.17 Thousand | -231.9 Thousand |
| Breakdown | 2022 FY | 2021 FY | 2020 FY |
|---|---|---|---|
| Operating Cash Flow | - | - | - |
| Net Income | -394.99 Thousand | -91.71 Thousand | -286.77 Thousand |
| Depreciation & Amortization | 65.6 Thousand | 66.4 Thousand | 3199.00 |
| Deferred income taxes | - | - | - |
| Stock-based compensation | - | - | - |
| Change in working capital | 54.28 Thousand | -140.45 Thousand | 73.24 Thousand |
| Other non-cash items | 49.61 Thousand | 346.71 Thousand | -136.35 Thousand |
| Investing Cash Flow | -1128.00 | - | -991.67 Thousand |
| Investments in PPE | - | - | - |
| Acquisitions | - | - | - |
| Investment purchases | - | - | - |
| Sales/Maturities of investments | - | - | - |
| Other Investing Activities | -1128.00 | - | -991.67 Thousand |
| Financing Cash Flow | 725 Thousand | - | 1.13 Million |
| Debt repayment | - | - | - |
| Dividends payments | - | - | - |
| Common Stock Repurchased | - | - | - |
| Common Stock Issuance | 725 Thousand | - | - |
| Other Financing Activities | - | - | 1.13 Million |
| Accounts receivables | -6915.00 | -1928.00 | 7984.00 |
| Accounts payables | 55.41 Thousand | -128.39 Thousand | 113.2 Thousand |
| Inventory | - | - | - |
| Other working capital | 5787.00 | -10.13 Thousand | -47.94 Thousand |
| Cash at beginning of period | 10.22 Thousand | 92.4 Thousand | 183.79 Thousand |
| Cash at end of period | 425.89 Thousand | 10.22 Thousand | 92.4 Thousand |
| Capital Expenditure | - | - | - |
| Effect of forex changes on cash | - | - | - |
| Net cash flow / Change in cash | 415.66 Thousand | -82.17 Thousand | -91.39 Thousand |
| Free Cash Flow | -308.2 Thousand | -82.17 Thousand | -231.9 Thousand |
MITUF
JBCHEPHARM
RFG
6827
300133
ROX